246 related articles for article (PubMed ID: 32807083)
1. Appropriate use of anti-thrombotic therapy in patients with atrial fibrillation at single-center experience, Northwest Ethiopia.
Endewunet E; Tadesse A; Adane A; Abdulkadir M
BMC Cardiovasc Disord; 2020 Aug; 20(1):375. PubMed ID: 32807083
[TBL] [Abstract][Full Text] [Related]
2. Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey.
Sabouret P; Bricard M; Hermann MA; Cotté FE; Deret-Bixio L; Rushton-Smith S
Arch Cardiovasc Dis; 2015 Nov; 108(11):544-53. PubMed ID: 26113478
[TBL] [Abstract][Full Text] [Related]
3. Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals.
Joseph PG; Healey JS; Raina P; Connolly SJ; Ibrahim Q; Gupta R; Avezum A; Dans AL; Lopez-Jaramillo P; Yeates K; Teo K; Douma R; Bahonar A; Chifamba J; Lanas F; Dagenais GR; Lear SA; Kumar R; Kengne AP; Keskinler M; Mohan V; Mony P; Alhabib KF; Huisman H; Iype T; Zatonska K; Ismail R; Kazmi K; Rosengren A; Rahman O; Yusufali A; Wei L; Orlandini A; Islam S; Rangarajan S; Yusuf S;
Cardiovasc Res; 2021 May; 117(6):1523-1531. PubMed ID: 32777820
[TBL] [Abstract][Full Text] [Related]
4. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation.
Giustozzi M; Agnelli G; Quattrocchi S; Acciarresi M; Alberti A; Caso V; Vedovati MC; Venti M; Paciaroni M
Cerebrovasc Dis Extra; 2020; 10(2):44-49. PubMed ID: 32375143
[TBL] [Abstract][Full Text] [Related]
5. Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study.
Gulizia MM; Cemin R; Colivicchi F; De Luca L; Di Lenarda A; Boriani G; Di Pasquale G; Nardi F; Scherillo M; Lucci D; Fabbri G; Maggioni AP;
Europace; 2019 Feb; 21(2):230-238. PubMed ID: 30060174
[TBL] [Abstract][Full Text] [Related]
6. Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey.
Dan GA; Iliodromitis K; Scherr D; Marín F; Lenarczyk R; Estner HL; Kostkiewicz M; Dagres N; Lip GYH
Europace; 2018 Aug; 20(8):1382-1387. PubMed ID: 29893840
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Medications for Atrial Fibrillation Among Older Women: Results From the Australian Longitudinal Study on Women's Health.
Abbas SS; Majeed T; Nair BR; Forder PM; Biostatistics M; Weaver N; Byles JE
J Cardiovasc Pharmacol Ther; 2021 Jan; 26(1):59-66. PubMed ID: 32757782
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
Dupree L; DeLosSantos M; Smotherman C
J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
[TBL] [Abstract][Full Text] [Related]
9. Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study.
Proietti M; Nobili A; Raparelli V; Napoleone L; Mannucci PM; Lip GY;
Clin Res Cardiol; 2016 Nov; 105(11):912-920. PubMed ID: 27245329
[TBL] [Abstract][Full Text] [Related]
10. Treatment patterns in anticoagulant therapy in patients with newly diagnosed atrial fibrillation in Belgium: results from the GARFIELD-AF registry.
Cools F; Wollaert B; Vervoort G; Verstraete S; Voet J; Hermans K; Heyse A; De Wolf A; Hollanders G; Boussy T; Anné W; Vercammen J; Faes D; Beutels M; Mairesse G; Purnode P; Blankoff I; Vandergoten P; Capiau L; Allu J; Bassand JP; Kayani G;
Acta Cardiol; 2019 Aug; 74(4):309-318. PubMed ID: 30369290
[No Abstract] [Full Text] [Related]
11. Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia.
Wertheimer G; Bereznicki LR
J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):46-53. PubMed ID: 29962220
[TBL] [Abstract][Full Text] [Related]
12. Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT Registry.
Boivin-Proulx LA; Deneault-Marchand A; Matteau A; Mansour S; Gobeil F; Camm JA; Fox KAA; Potter BJ
Clin Cardiol; 2020 Mar; 43(3):216-221. PubMed ID: 31850592
[TBL] [Abstract][Full Text] [Related]
13. Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study.
Liu T; Yang HL; Gu L; Hui J; Omorogieva O; Ren MX; Wang XH
BMC Cardiovasc Disord; 2020 Jan; 20(1):22. PubMed ID: 31948390
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
[TBL] [Abstract][Full Text] [Related]
15. Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.
Camm AJ; Accetta G; Ambrosio G; Atar D; Bassand JP; Berge E; Cools F; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Kayani G; Koretsune Y; Mantovani LG; Misselwitz F; Oh S; Turpie AG; Verheugt FW; Kakkar AK;
Heart; 2017 Feb; 103(4):307-314. PubMed ID: 27647168
[TBL] [Abstract][Full Text] [Related]
16. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
[TBL] [Abstract][Full Text] [Related]
17. Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice.
Falissard B; Picard F; Mahe I; Hanon O; Touzé E; Danchin N; Lamy FX; Ricci L; Steg PG
Arch Cardiovasc Dis; 2019; 112(6-7):400-409. PubMed ID: 31014991
[TBL] [Abstract][Full Text] [Related]
18. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey.
Potpara TS; Lenarczyk R; Larsen TB; Deharo JC; Chen J; Dagres N;
Europace; 2015 Dec; 17(12):1862-7. PubMed ID: 26733617
[TBL] [Abstract][Full Text] [Related]
19. Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
Olivier CB; Fan J; Askari M; Mahaffey KW; Heidenreich PA; Perino AC; Leef GC; Ho PM; Harrington RA; Turakhia MP
Circ Cardiovasc Interv; 2019 Aug; 12(8):e007604. PubMed ID: 31416357
[TBL] [Abstract][Full Text] [Related]
20. Barriers to warfarin use for stroke prevention in patients with atrial fibrillation in Hong Kong.
Lee VW; Tam CS; Yan BP; Man Yu C; Yin Lam Y
Clin Cardiol; 2013 Mar; 36(3):166-71. PubMed ID: 23151816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]